SKYESkye Bioscience, Inc.

Nasdaq skyebioscience.com


$ 5.37 $ -1.96 (-26.27 %)    

Friday, 05-Jul-2024 15:52:53 EDT
QQQ $ 495.80 $ 5.12 (1.04 %)
DIA $ 393.71 $ 0.87 (0.22 %)
SPY $ 554.29 $ 3.18 (0.58 %)
TLT $ 92.56 $ 0.76 (0.83 %)
GLD $ 220.89 $ 2.94 (1.35 %)
$ 5.5
$ 7.33
$ 5.54 x 100
$ 0.00 x 0
$ 5.25 - $ 7.33
$ 0.01 - $ 19.41
352,815
na
154M
$ -14.70
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-10-2024 03-31-2024 10-Q
2 03-22-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-07-2023 06-30-2023 10-Q
5 05-12-2023 03-31-2023 10-Q
6 03-31-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-06-2022 03-31-2022 10-Q
10 03-25-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-06-2021 06-30-2021 10-Q
13 05-07-2021 03-31-2021 10-Q
14 03-02-2021 12-31-2020 10-K
15 11-06-2020 09-30-2020 10-Q
16 08-13-2020 06-30-2020 10-Q
17 05-08-2020 03-31-2020 10-Q
18 03-23-2020 12-31-2019 10-K
19 11-14-2019 09-30-2019 10-Q
20 08-09-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 03-14-2019 12-31-2018 10-K
23 11-14-2018 09-30-2018 10-Q
24 08-10-2018 06-30-2018 10-Q
25 05-15-2018 03-31-2018 10-Q
26 03-19-2018 12-31-2017 10-K
27 11-14-2017 09-30-2017 10-Q
28 08-11-2017 06-30-2017 10-Q
29 05-12-2017 03-31-2017 10-Q
30 03-10-2017 12-31-2016 10-K
31 11-09-2016 09-30-2016 10-Q
32 08-12-2016 06-30-2016 10-Q
33 05-13-2016 03-31-2016 10-Q
34 03-21-2016 12-31-2015 10-K
35 11-12-2015 09-30-2015 10-Q
36 08-14-2015 06-30-2015 10-Q
37 05-13-2015 03-31-2015 10-Q
38 03-27-2015 12-31-2014 10-K
39 11-14-2014 09-30-2014 10-Q
40 09-15-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Cantor Fitzgerald analyst Kristen Kluska reiterates Skye Bioscience (NASDAQ:SKYE) with a Overweight and maintains $14 price ...

Core News & Articles

Cantor Fitzgerald analyst Kristen Kluska reiterates Skye Bioscience (NASDAQ:SKYE) with a Overweight and maintains $14 price ...

Core News & Articles

Cantor Fitzgerald analyst Kristen Kluska reiterates Skye Bioscience (NASDAQ:SKYE) with a Overweight and maintains $14 price ...

Core News & Articles
Market-Moving News for June 10th
06/10/2024 12:40:57

DSY: 255% | Big Tree Cloud shares are trading higher following the completion of the company's business combination with Pl...

Core News & Articles

Cantor Fitzgerald analyst Kristen Kluska initiates coverage on Skye Bioscience (NASDAQ:SKYE) with a Overweight rating and an...

Core News & Articles

 - SEC Filing

Core News & Articles

Oppenheimer analyst Jay Olson initiates coverage on Skye Bioscience (NASDAQ:SKYE) with a Outperform rating and announces Pri...

Core News & Articles

Piper Sandler analyst Edward Tenthoff reiterates Skye Bioscience (OTC:SKYE) with a Overweight and raises the price target fr...

 skye-bioscience-and-2-other-penny-stocks-insiders-are-buying

The Dow Jones index closed higher by more than 100 points on Friday. When insiders purchase or sell shares, it indicates their ...

Core News & Articles

Piper Sandler analyst Edward Tenthoff initiates coverage on Skye Bioscience (OTC:SKYE) with a Overweight rating and announce...